Assignee
DENALI THERAPEUTICS INC
US·52 granted patents·70 pending applications·169 citations·filing 2016–2025
Top patents by PatentIndex Score
122 records- 0197US11111235B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2020·Granted Sep 7, 2021·7 cites·26 claims
- 0297US9896458B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Feb 20, 2018·23 cites·6 claims
- 0397US9815850B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Nov 14, 2017·36 cites·41 claims
- 0496US11912778B2Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2022·Granted Feb 27, 2024·2 cites·17 claims
- 0596US10143187B2Transferrin receptor transgenic modelsDENALI THERAPEUTICS INC·Filed 2018·Granted Dec 4, 2018·12 cites·34 claims
- 0696US9932325B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Apr 3, 2018·16 cites·30 claims
- 0795US11124567B2Anti-TREM2 antibodies and methods of use thereofDENALI THERAPEUTICS INC·Filed 2021·Granted Sep 21, 2021·16 cites·31 claims
- 0895US10457717B2Engineered polypeptidesDENALI THERAPEUTICS INC·Filed 2018·Granted Oct 29, 2019·11 cites·29 claims
- 0993US12162948B2Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Granted Dec 10, 2024·1 cites·16 claims
- 1093US10870837B2Fusion proteins comprising enzyme replacement therapy enzymesDENALI THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·9 cites·47 claims
- 1191US11884944B2Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods thereofDENALI THERAPEUTICS INC·Filed 2022·Granted Jan 30, 2024·2 cites·39 claims
- 1291US11306077B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Apr 19, 2022·2 cites·47 claims
- 1391US10370361B2Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of productionDENALI THERAPEUTICS INC·Filed 2018·Granted Aug 6, 2019·3 cites·27 claims
- 1490US11591316B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Feb 28, 2023·1 cites·20 claims
- 1590US10590114B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Mar 17, 2020·5 cites·27 claims
- 1689US11866742B2Fusion proteins comprising enzyme replacement therapy enzymesDENALI THERAPEUTICS INC·Filed 2020·Granted Jan 9, 2024·2 cites·35 claims
- 1789US11643446B2Progranulin variantsDENALI THERAPEUTICS INC·Filed 2022·Granted May 9, 2023·4 cites·50 claims
- 1889US2025034119A1Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1988US11795232B2Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2019·Granted Oct 24, 2023·2 cites·38 claims
- 2088US2024141058A1Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2187US2024018253A1Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2286US10604535B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Mar 31, 2020·3 cites·18 claims
- 2386US10131676B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Nov 20, 2018·3 cites·33 claims
- 2485US12358928B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2023·Granted Jul 15, 2025·0 cites·8 claims
- 2585US11834439B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2023·Granted Dec 5, 2023·0 cites·19 claims
- 2685US2025297023A1Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2784US2025388601A1Compounds, Compositions and MethodsDENALI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2883US11203600B2Kinase inhibitors and uses thereofDENALI THERAPEUTICS INC·Filed 2019·Granted Dec 21, 2021·2 cites·24 claims
- 2982US2024024432A1Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3082US2024271326A1Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3180US11236100B2Modulators of eukaryotic initiation factor 2B, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Feb 1, 2022·1 cites·30 claims
- 3280US2025011338A1Kinase Inhibitors and Uses ThereofDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3379US12240902B2Anti-TREM2 antibodies and methods of use thereofDENALI THERAPEUTICS INC·Filed 2021·Granted Mar 4, 2025·1 cites·20 claims
- 3479US11834438B2Process for the preparation of pyrimidinyl-4-aminopyrazole compoundsDENALI THERAPEUTICS INC·Filed 2018·Granted Dec 5, 2023·1 cites·6 claims
- 3579US2026079170A1Methods for treating and monitoring progranulin-associated disordersDENALI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3679US2024140919A1Modulators of eukaryotic initiation factor 2DENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3778US10851088B2Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of productionDENALI THERAPEUTICS INC·Filed 2019·Granted Dec 1, 2020·1 cites·25 claims
- 3878US2025367284A1Anti-transferrin receptor fusion proteins and methods of use thereofDENALI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3978US2025387477A1Anti-transferrin receptor fusion proteins and methods of use thereofDENALI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4076US11028080B2Substituted pyrimidines as LRKK2 inhibitorsDENALI THERAPEUTICS INC·Filed 2017·Granted Jun 8, 2021·1 cites·53 claims
- 4176US2023381286A1Affinity-based methods for using transferrin receptor-binding proteinsDENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4276US2023250072A1Modulators of eukaryotic initiation factor 2DENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4375US11851440B2Modulators of eukaryotic initiation factor 2B, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Dec 26, 2023·0 cites·18 claims
- 4475US2025122159A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4574US12497387B2Process for the preparation of pyrimidinyl-4-aminopyrazole compoundsDENALI THERAPEUTICS INC·Filed 2023·Granted Dec 16, 2025·0 cites·5 claims
- 4674US11427571B2Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of productionDENALI THERAPEUTICS INC·Filed 2020·Granted Aug 30, 2022·0 cites·2 claims
- 4774US2023265137A1Progranulin variantsDENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4873US12139478B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Nov 12, 2024·1 cites·57 claims
- 4973US2024150736A1Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods thereofDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 5073US2023043400A1Compounds, Compositions and MethodsDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 122 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →